The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Peripheral biomarker analysis in patients with advanced urothelial carcinoma (UC) after platinum chemotherapy treated with cabozantinib (CABO) plus durvalumab (DURVA): Preliminary analysis from the phase 2 ARCADIA trial.
 
Patrizia Giannatempo
Honoraria - Astellas Pharma; Gilead Sciences; Janssen medical Affairs; Pfizer
Consulting or Advisory Role - Astellas Pharma; Gilead Sciences; Janssen Oncology; Merck; Pfizer
Research Funding - AstraZeneca; Ipsen; MSD Oncology
Travel, Accommodations, Expenses - Bristol-Myers Squibb/Roche; Bristol-Myers Squibb/Roche; Pfizer
 
Francesco Sgambelluri
No Relationships to Disclose
 
Marco Stellato
No Relationships to Disclose
 
Valentina Guadalupi
No Relationships to Disclose
 
Daniele Raggi
No Relationships to Disclose
 
Alessandro Rametta
No Relationships to Disclose
 
Achille Bottiglieri
No Relationships to Disclose
 
Melanie Claps
No Relationships to Disclose
 
Ferrari Bravo Walter
No Relationships to Disclose
 
Simone Oldani
No Relationships to Disclose
 
Matteo Zimatore
No Relationships to Disclose
 
Giuseppina Calareso
No Relationships to Disclose
 
Alessandra Alessi
No Relationships to Disclose
 
Laura Cattaneo
No Relationships to Disclose
 
Elena Verzoni
Consulting or Advisory Role - Janssen Oncology; MSD/AstraZeneca; Pfizer
Speakers' Bureau - Ipsen; Janssen Oncology; MSD Oncology; Novartis
 
Filippo G. De Braud
No Relationships to Disclose
 
Giuseppe Procopio
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb (BMS); Eisai; Ipsen; Janssen; Merck Sharp & Dohme; MSD Oncology; Novartis; Pfizer; Roche
Research Funding - Astellas Pharma; Ipsen; Janssen Oncology
 
Andrea Necchi
Employment - Bayer (I)
Stock and Other Ownership Interests - Bayer (I)
Honoraria - Astellas Pharma; AstraZeneca; Bristol-Myers Squibb; Foundation Medicine; Janssen; Merck; Roche
Consulting or Advisory Role - AstraZeneca; Basilea Pharmaceutical; Bayer; Bristol-Myers Squibb; Catalym; Clovis Oncology; GlaxoSmithKline; Incyte; Janssen; Merck Sharp & Dohme; Rainier Therapeutics; Roche; Seattle Genetics/Astellas
Research Funding - AstraZeneca (Inst); Gilead Sciences; Ipsen; Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Janssen; Merck Sharp & Dohme; Pfizer; Rainier Therapeutics; Roche
Other Relationship - Bayer (I)
 
Andrea Anichini
No Relationships to Disclose
 
Roberta Mortarini
No Relationships to Disclose